| Product Code: ETC9951611 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Personalized Cancer Medicine Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Personalized Cancer Medicine Market - Industry Life Cycle |
3.4 United Kingdom (UK) Personalized Cancer Medicine Market - Porter's Five Forces |
3.5 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Personalized Cancer Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Advancements in personalized medicine technology |
4.2.2 Increasing prevalence of cancer in the UK |
4.2.3 Growing awareness about the benefits of personalized cancer medicine |
4.3 Market Restraints |
4.3.1 High cost associated with personalized cancer medicine |
4.3.2 Stringent regulatory requirements for personalized medicine |
4.3.3 Limited access to specialized healthcare facilities offering personalized cancer treatments |
5 United Kingdom (UK) Personalized Cancer Medicine Market Trends |
6 United Kingdom (UK) Personalized Cancer Medicine Market, By Types |
6.1 United Kingdom (UK) Personalized Cancer Medicine Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Diagnostics, 2021- 2031F |
6.1.4 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Therapeutics, 2021- 2031F |
6.2 United Kingdom (UK) Personalized Cancer Medicine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.2.3 United Kingdom (UK) Personalized Cancer Medicine Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Personalized Cancer Medicine Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Personalized Cancer Medicine Market Export to Major Countries |
7.2 United Kingdom (UK) Personalized Cancer Medicine Market Imports from Major Countries |
8 United Kingdom (UK) Personalized Cancer Medicine Market Key Performance Indicators |
8.1 Number of clinical trials focusing on personalized cancer medicine in the UK |
8.2 Adoption rate of personalized cancer medicine by healthcare providers |
8.3 Patient satisfaction and outcomes with personalized cancer treatments |
8.4 Investment in research and development for personalized cancer medicine in the UK |
8.5 Availability and accessibility of genetic testing services in the UK |
9 United Kingdom (UK) Personalized Cancer Medicine Market - Opportunity Assessment |
9.1 United Kingdom (UK) Personalized Cancer Medicine Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Personalized Cancer Medicine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Personalized Cancer Medicine Market - Competitive Landscape |
10.1 United Kingdom (UK) Personalized Cancer Medicine Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Personalized Cancer Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here